GlassScriptPhysician profile
Cynthia Escobar
NPI 1568890952
$3,734.40
in general payments reported to CMS, 2019-2025
20 companies · $805 in 2025
The $805 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $374 · 2022: $902 · 2023: $992 · 2024: $662 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,135 · Education: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,135.48 |
| Education | $323.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $1,077.14 | 2021-2025 | Enhertu |
| Seagen INC. | $529.78 | 2021-2025 | |
| Lilly USA, LLC | $486.60 | 2022-2025 | Verzenio, Retevmo |
| Novartis Pharmaceuticals Corporation | $457.43 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $274.00 | 2021-2025 | Enhertu |
| Puma Biotechnology, INC. | $176.43 | 2022-2024 | |
| Shionogi INC | $121.84 | 2025 | Fetroja |
| Stemline Therapeutics INC. | $121.66 | 2023-2025 | Orserdu |
| Gilead Sciences, INC. | $87.88 | 2024 | Trodelvy |
| Merck Sharp & Dohme LLC | $83.47 | 2024-2025 | Keytruda, Lynparza |
| Pfizer INC. | $71.39 | 2022-2024 | |
| Caris Mpi, INC. | $48.03 | 2025 | Mi Cancer Seek |
| Eisai INC. | $34.89 | 2022-2024 | |
| Genentech USA, INC. | $31.40 | 2025 | Itovebi |
| Takeda Pharmaceuticals U.S.A., INC. | $29.38 | 2024 | Alunbrig |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $23.76 | 2024 | Myrisk |
| Foundation Medicine, INC. | $23.15 | 2022 | |
| Tersera Therapeutics LLC | $20.17 | 2022 | |
| Amgen INC. | $19.58 | 2023 | Prolia, Evenity |
| Dynavax Technologies Corporation | $16.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Escobar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.